Brian T. Dorsey
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian T. Dorsey
Brian T. Dorsey was last confirmed as COO at ARS Pharmaceuticals, Inc. (SPRY) in a filing dated April 29, 2025. ARS Pharmaceuticals, Inc. reported in an 8-K filed December 9, 2022 that Brian T. Dorsey was appointed Chief Operations Officer, effective December 6, 2022. The proxy statement of ARS Pharmaceuticals, Inc. reports total compensation of $2,235,070 for Brian T. Dorsey in fiscal 2024, including a base salary of $451,000.
“Effective as of December 6, 2022, ARS Pharmaceuticals, Inc. (the “Company”) appointed Brian T. Dorsey, MSc, as Chief Operations Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2022-12-06–2025-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | ARS Pharmaceuticals, Inc. (SPRY) | MSc Chief Operating Officer | $451,000 | $2,235,070 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.